Generate a tailored SOP for Dr. Henry Dunn. Improve your application with a focused, well-structured draft.
Henry Dunn is an assistant professor in the Department of Pharmacology and Therapeutics at the University of Manitoba and principal investigator at the St. Boniface Hospital Albrechtsen Research Centre. He leads the Molecular Pharmacology Neuropsychiatric Disease Lab with a focus on G protein-coupled receptors (GPCRs), specifically their molecular mechanisms in stress-induced anxiety and depression. His research contributes to understanding attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and epilepsy. Dunn's work has revealed relationships between synaptic adhesion molecules and synaptic GPCRs that could influence novel drug design for neuropsychiatric diseases. He has an extensive background with interdisciplinary approaches including molecular pharmacology, biochemistry, cellular neurobiology, and behavioral neuroscience. Hold degrees from the University of Western Ontario, Dunn completed a postdoctoral fellowship at the Scripps Research Institute and another at the University of Ottawa, with several awards including the Natural Science and Engineering Research Council Canada's Discovery Grant.
Streams include Education, Administration, or Clinical.